Relx PLC ADR EBITDA

Mitä Relx PLC ADR tekee? Relx PLC ADR, traded under the ticker RELX, is a company incorporated in 1903 and headquartered in London, United Kingdom. It operates as a provider of information-based analytics and decision tools for professional and business customers across North America, Europe, and internationally. The company's operations are structured into four segments: Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The Risk segment delivers analytics and decision tools that integrate public and industry-specific content with technology and algorithms to help clients assess and predict risk, alongside a range of commercial healthcare products. The Scientific, Technical & Medical segment offers scientific and medical information and data sets for use in research and healthcare applications. The Legal segment provides legal, regulatory, and business information with accompanying analytics. The Exhibitions segment combines digital tools and data to facilitate in-person and online connections, market exploration, product sourcing, lead generation, and transactions for its clients. Relx PLC was formerly known as Reed Elsevier PLC, adopting its current name in July 2015. The company has a workforce of 37,000 employees and went public on October 7, 1994. Its website is www.relx.com. Relx PLC ADR is listed on U.S. markets with ISIN US7595301083. Relx PLC ADR on yksi Eurpooliin suosituimmista yhtiöistä.